Michelle DeMeo, Senior Program Manager at Dana-Farber Cancer Institute, shared on X:
“Congratulations to Maxwell Lloyd, Kevin Kalinsky, Aditya Bardia, Komal Jhaveri and Seth Wander for recently published review of precision therapeutics and emerging strategies in HR+ MBC (metastatic breast cancer) in Nature Reviews Clinical Oncology.”
Precision therapeutics and emerging strategies for HR-positive metastatic breast cancer
Authors: Maxwell Lloyd, Kevin Kalinsky, Aditya Bardia, Komal Jhaveri and Seth Wander.
Source: Michelle DeMeo/X